Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Aptuit has announced that Dr. Maurizio Denaro has assumed responsibilities as General Manager of The Aptuit Center for Discovery & Development in Verona, Italy, effective July 15, 2013.
read more
Monday, February 11, 2013
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced the availability of GLP-qPCR Biodistribution Studies required as part of the preclinical development study package for application in First In Man (FIM) of Gene Therapy ...
read more
Wednesday, March 27, 2013
Aptuit announces that it offers fast screenings of synaptic activity on hippocampal slices for clients who are focused on the central nervous system (CNS) therapeutic area.
read more
Thursday, October 31, 2013
Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, today announces a three-year extension of its integrated contract drug discovery agreement with Genentech, a member of ...
read more
Thursday, January 08, 2015
Bob Hartwig, North American Representative for DIR Technologies – a provider of quality and process control solutions for pharmaceutical primary packaging – will deliver a presentation at Pack Expo East on the potential of disruptive technology and ...
read more
Today, ATS Labs, Inc. (ATS), majority owned by Ampersand Capital
Partners, announced that it acquired the assets of MicroTest Labs, Inc. (MTL) of Agawam, MA. The
acquisition of MTL is the first step in the strategy of ATS to expand its microbiology...
read more
Bioanalytical Systems, Inc. (NASDAQ:BASI)
today announced the appointment of Jeffrey Potrzebowski as Chief Financial Officer and James S. Bourdage, Ph.D., as Vice President Bioanalytical Operations.
read more
BioDuro, A PPD® Company, today announced it has opened a new state-of-the-art laboratory in Shanghai, strengthening its ability to provide biopharmaceutical clients an extensive range of customized drug discovery services in Asia Pacific. The new lab...
read more
Tuesday, February 18, 2014
BioOutsource Ltd. (“BioOutsource”), a global leader in biologics contract testing and biosimilar characterization for the biopharmaceutical industry, today announced the opening of a new Biosimilar Centre of Excellence in Glasgow. The new facility ...
read more
Wednesday, March 06, 2013
Sigma-Aldrich® Corporation today announced that BioReliance® (http://www.bioreliance.com), the biologics and early development services business under SAFC® (www.safcglobal.com), has signed an agreement to acquire the colonies required for the Big ...
read more
Thursday, October 31, 2013
The U.S. regulatory landscape changed dramatically 10 years ago. In 2003, legal roadblocks to the 505(b)(2) approval pathway were resolved, making it a practical alternative route for drug development. That same year, Ken Phelps and Ruth Stevens ...
read more
The U.S. regulatory landscape has changed dramatically in 10 years. In 2003, the FDA finally resolved legal hurdles to the 505(b)(2) approval pathway, making it a practical alternative route for drug development. The same year, Ken Phelps and Ruth ...
read more
Tuesday, February 18, 2014
Camargo Pharmaceutical Services’ Ready 4 Action
proprietary feasibility assessment enables drug developers — generic companies in particular
— to identify viable products to bring to market. Camargo will be exhibiting at the Generic
Pharmaceutical...
read more
Tuesday, September 17, 2013
Global pharmaceutical chemistry leader Cambridge Major Laboratories, Inc. (CML) is pleased to announce the appointment of Dr. Mark Sawicki as Chief Business Officer. With executive leadership responsibility for the global sales and marketing ...
read more
Friday, December 12, 2014
Capillary Film Technology Limited (CFT), a UK based technology and product development company for life sciences and clinical diagnostics, today announced it has received £1 million in funding through a Phase 2 Small Business Research Initiative for ...
read more